Skip to main content
Erschienen in: Inflammopharmacology 6/2013

01.12.2013 | Erratum

Erratum to: Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis

verfasst von: V. L. Kumar, B. Guruprasad, V. D. Wahane

Erschienen in: Inflammopharmacology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Excerpt

After publication of this work an overlap in the values of increase in joint diameter on day 3 in different groups and panel a of Fig. 3 with those in our previous paper (Wahane and Kumar 2010) was brought to our attention. These studies were part of the same project and this error resulted due to an oversight. Day 3 values for increase in joint diameter for the original article are—FC: 4.24 ± 0.13 mm; D5: 3.10 ± 0.09 mm; A10: 3.48 ± 0.12 mm; A50: 2.87 ± 0.11 mm (27, 18 and 32 % inhibition, respectively). Panel a of Fig. 3 was used for reference purpose in these papers. …
Literatur
Zurück zum Zitat Wahane VD, Kumar VL (2010) Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis. Pharmacol Res 61:329–333PubMedCrossRef Wahane VD, Kumar VL (2010) Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis. Pharmacol Res 61:329–333PubMedCrossRef
Metadaten
Titel
Erratum to: Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis
verfasst von
V. L. Kumar
B. Guruprasad
V. D. Wahane
Publikationsdatum
01.12.2013
Verlag
Springer Basel
Erschienen in
Inflammopharmacology / Ausgabe 6/2013
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-013-0185-5

Weitere Artikel der Ausgabe 6/2013

Inflammopharmacology 6/2013 Zur Ausgabe